Abstract
Tissues subjected to stress, for example due to mechanical injury, environmental exposures, or endogenous signals, possess a remarkable ability to respond, adapting to limit stress, protect the tissue from further injury, and promote normal tissue recovery. This involves the coordinated activation and regulation of multiple processes, including infiltration by inflammatory cells to remove damaged cells and debris, angiogenesis, extracellular matrix turnover, and progenitor cell expansion and differentiation to regenerate normal tissue. However, in some circumstances inappropriate tissue responses occur, for example acute or prolonged overreactions, wherein the underlying processes are exaggerated and dysregulated, resulting in maladaptive tissue remodeling. A prominent feature of such pathological tissue responses is robust inflammation, as occurs in chronic autoimmune and inflammatory diseases, leading to cell death, progressive damage, and pathological remodeling of the disease target tissue. In the past decade, the ctokine TWEAK and its receptor FN14 have emerged as a ligand/receptor pair of the TNF superfamily that is prominently featured in normal and pathological tissue remodeling. TWEAK/Fn14-induced activities contribute to progressive local tissue damage, maladaptive remodeling, and worsened outcomes in animal models of inflammatory disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Burkly LC et al (2007) TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. Cytokine 40(1):1–16
Winkles JA (2008) The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov 7(5):411–425
Zheng TS, Burkly LC (2008) No end in site: TWEAK/Fn14 activation and autoimmunity associated- end-organ pathologies. J Leukoc Biol 84(2): 338–347
Dohi T et al (2009) TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis. Gastroenterology 136(3):912–923
Chicheportiche Y et al (1997) TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem 272(51):32401–32410
Felli N et al (2005) Multiple members of the TNF superfamily contribute to IFN-gamma-mediated inhibition of erythropoiesis. J Immunol 175(3):1464–1472
Kaplan MJ et al (2002) The apoptotic ligands TRAIL, TWEAK, and Fas ligand mediate monocyte death induced by autologous lupus T cells. J Immunol 169(10):6020–6029
Kawakita T et al (2004) Functional expression of TWEAK in human hepatocellular carcinoma: possible implication in cell proliferation and tumor angiogenesis. Biochem Biophys Res Commun 318(3):726–733
Desplat-Jego S et al (2009) TWEAK is expressed at the cell surface of monocytes during multiple sclerosis. J Leukoc Biol 85(1):132–135
van Kuijk AW et al (2009) TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to TNF blockade. Ann Rheum Dis 69(1):301–304
Serafini B et al (2008) Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury. J Neuropathol Exp Neurol 67(12):1137–1148
Inta I et al (2008) Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke. J Neurol Sci 275(1–2):117–120
Schwartz N et al (2006) Urinary TWEAK and the activity of lupus nephritis. J Autoimmun 27(4):242–250
Wiley SR et al (2001) A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity 15(5):837–846
Meighan-Mantha RL et al (1999) The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J Biol Chem 274(46):33166–33176
Perper SJ et al (2006) TWEAK is a novel arthritogenic mediator. J Immunol 177(4):2610–2620
Zhao Z et al (2007) TWEAK/Fn14 Interactions are instrumental in the pathogenesis of nephritis in the chronic graft-versus-host model of systemic lupus erythematosus. J Immunol 179(11):7949–7958
Jakubowski A et al (2002) Dual role for TWEAK in angiogenic regulation. J Cell Sci 115(Pt 2):267–274
Chorianopoulos E et al (2009) FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK. Basic Res Cardiol 105(2):301–313
Munoz-Garcia B et al (2009) Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice. Arterioscler Thromb Vasc Biol
Girgenrath M et al (2006) TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. Embo J 25(24):5826–5839
Justo P et al (2006) Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int 70(10):1750–1758
Desplat-Jego S et al (2005) Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis. Clin Immunol 117(1):15–23
Potrovita I et al (2004) Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration. J Neurosci 24(38):8237–8244
Yepes M et al (2005) A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia. Am J Pathol 166(2):511–520
Jakubowski A et al (2005) TWEAK induces liver progenitor cell proliferation. J Clin Invest 115(9):2330–2340
Saitoh T et al (2003) TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation. J Biol Chem 278(38):36005–36012
Nakayama M et al (2002) Multiple pathways of TWEAK-induced cell death. J Immunol 168(2):734–743
Vince CE et al (2008) TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFα. J Cell Biol 182(1):171–184
Wicovsky A et al (2009) TNF-like weak inducer of apoptosis inhibits proinflammatory TNF receptor-1 signaling. Cell Death Differ 16(11):1445–1459
Maecker H et al (2005) TWEAK attenuates the transition from innate to adaptive immunity. Cell 123(5):931–944
Jain M et al (2009) A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Circulation 119(15):2058–2068
Dogra C et al (2007) TNF-related weak inducer of apoptosis (TWEAK) is a potent skeletal muscle-wasting cytokine. FASEB J 21(8):1857–1869
Desplat-Jego S et al (2002) TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity. J Neuroimmunol 133(1–2):116–123
Polavarapu R et al (2005) Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation. J Neurosci 25(44):10094–10100
Campbell S et al (2006) Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cells. J Immunol 176(3):1889–1898
Gao HX et al (2009) TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells. Cytokine 46(1):24–35
Sanz AB et al (2008) The cytokine TWEAK modulates renal tubulointerstitial inflammation. J Am Soc Nephrol 19(4):695–703
Kamata K et al (2006) Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis. J Immunol 177(9):6433–6439
Mueller AM et al (2005) Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 159(1-2):55–65
Schapira K et al (2009) Fn14-Fc fusion protein regulates atherosclerosis in ApoE–/– mice and inhibits macrophage lipid uptake in vitro. Arterioscler Thromb Vasc Biol 29(12):2021–2027
Sanz AB et al (2009) Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy-induced renal hyperplasia. J Cell Mol Med 13(9B):3329–3342
Iocca HA et al (2008) TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model. J Neuroimmunol 194(1–2):97–106
Zhang X et al (2007) TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia. J Cereb Blood Flow Metab 27(3):534–544
Abreu MT, Fukata M, Arditi M (2005) TLR signaling in the gut in health and disease. J Immunol 174(8):4453–4460
Artis D (2008) Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 8(6):411–420
Gribar SC et al (2008) No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol Med 14(9–10):645–659
Galamb O et al (2008) Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature. Dis Markers 25(1):1–16
Gyorffy B et al (2009) Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples. PLoS One 4(5):e5645
Kugathasan S et al (2008) Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat Genet 40(10):1211–1215
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this paper
Cite this paper
Burkly, L.C., Dohi, T. (2011). The TWEAK/Fn14 Pathway in Tissue Remodeling: For Better or for Worse. In: Wallach, D., Kovalenko, A., Feldmann, M. (eds) Advances in TNF Family Research. Advances in Experimental Medicine and Biology, vol 691. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6612-4_32
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6612-4_32
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-6611-7
Online ISBN: 978-1-4419-6612-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)